| Unique ID issued by UMIN | UMIN000026776 |
|---|---|
| Receipt number | R000030730 |
| Scientific Title | Fluoroscopic guided-catheter insertion method for continuous femoral nerve block for analgesia after total knee arthroplasty: a prospective, one institutional, interventional study |
| Date of disclosure of the study information | 2017/04/14 |
| Last modified on | 2019/04/07 21:47:50 |
Fluoroscopic guided-catheter insertion method for continuous femoral nerve block for analgesia after total knee arthroplasty: a prospective, one institutional, interventional study
Fluoroscopic guided-catheter insertion method for continuous femoral nerve block for analgesia after total knee arthroplasty
Fluoroscopic guided-catheter insertion method for continuous femoral nerve block for analgesia after total knee arthroplasty: a prospective, one institutional, interventional study
Fluoroscopic guided-catheter insertion method for continuous femoral nerve block for analgesia after total knee arthroplasty
| Japan |
Osteoarthritis of the knee
| Orthopedics | Anesthesiology |
Others
NO
To investigate the effect of fluoroscopic guided-catheter insertion technique for continuous femoral nerve block for analgesia after total knee arthroplasty
Efficacy
Comparison of minimum current perception thresholds at four nerve-dominated areas (femoral nerve, obturator nerve, lateral femoral cutaneous nerve, sciatic nerve) on postoperative day 1, 3, and 6
Complications
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
| Device,equipment | Maneuver |
This technique is performed after spinal anesthesia preoperatively. A catheter is inserted from the outside of the femoral artery just below the inguinal ligament following confirmation of the position of the femoral nerve with a nerve stimulator. Subsequently, the catheter is cautiously advanced through a 50cm guide wire to the level of L5 under fluoroscopic guidance. The position of the catheter is confirmed with 10ml of a contrast agent in the frontal view of an X ray at the hip joint. After the operation, 0.2% ropivacaine is continuously administered at 5 ml/hr and then 0.125% ropivacaine is administered on postoperative day 2 through the catheter and until postoperative day 4, when the catheter is removed.
| 20 | years-old | <= |
| 100 | years-old | > |
Male and Female
Patients planning to total knee arthroplasty
Allergy to local anesthetic agents
Bleeding tendency
Severe liver dysfunction
Severe renal dysfunction
Incorporation to treatment
20
| 1st name | Toshio |
| Middle name | |
| Last name | Iwaki |
Matsuda Hospital
Department of Anesthesiology
710-0056
1-3-10, tsurugata, Kurashiki-shi, Okayama, Japan
086-422-3550
tenwaans@mx1.kct.ne.jp
| 1st name | Toshio |
| Middle name | |
| Last name | Iwaki |
Matsuda Hospital
Department of Anesthesiology
710-0056
1-3-10, tsurugata, Kurashiki-shi, Okayama, Japan
086-422-3550
tenwaans@mx1.kct.ne.jp
Matsuda Hospital
Matsuda Hospital
Self funding
Matsuda Hospital
1-3-10, tsurugata, Kurashiki-shi, Okayama, Japan
086-422-3550
tenwaans@mx1.kct.ne.jp
NO
天和会 松田病院(岡山県)
| 2017 | Year | 04 | Month | 14 | Day |
Unpublished
25
No longer recruiting
| 2017 | Year | 03 | Month | 29 | Day |
| 2017 | Year | 03 | Month | 29 | Day |
| 2017 | Year | 03 | Month | 29 | Day |
| 2019 | Year | 04 | Month | 01 | Day |
| 2019 | Year | 04 | Month | 01 | Day |
| 2019 | Year | 04 | Month | 15 | Day |
| 2019 | Year | 04 | Month | 15 | Day |
| 2017 | Year | 03 | Month | 30 | Day |
| 2019 | Year | 04 | Month | 07 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000030730